ArticleMethods in molecular biology (Clifton, N.J.)2026
Integration of Omics Data to Identify Cancer-Related MicroRNA.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are small noncoding RNAs that play critical regulatory roles in gene expression by targeting messenger RNAs (mRNAs) for degradation or translational inhibition. Their ability to modulate multiple genes simultaneously places them at the center of many biological processes, including those involved in tumorigenesis. Depending on their targets, miRNAs can act as oncogenes or tumor suppressors, contributing to cancer development and progression. Advances in high-throughput sequencing now allow simultaneous profiling of miRNA and mRNA expression in the same biological samples. When properly integrated, these datasets can uncover functional miRNA-mRNA regulatory networks, reveal cancer-specific signatures, and identify novel biomarkers or therapeutic targets. However, the integrative analysis of miRNA and mRNA expression data remains computationally challenging and requires well-structured pipelines and rigorous statistical approaches. In this chapter, we present updated computational strategies to identify biologically relevant miRNA-mRNA interactions through expression correlation, target prediction, and functional enrichment. The chapter includes step-by-step protocols, example R code, and recommendations for integrating additional data layers such as copy number variation and DNA methylation, with the goal of improving the robustness and interpretability of miRNA-based analyses in cancer.
Indexed as
Identifiers
42681328What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.